Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells

High-risk neuroblastoma remains a therapeutic challenge with a long-term survival rate of less than 40%. Therefore, new agents are urgently needed to overcome chemotherapy resistance so as to improve the treatment outcome of this deadly disease. Histone deacetylase (HDAC) inhibitors (HDACIs) represe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guan, Edwards, Holly, Caldwell, J. Timothy, Buck, Steven A., Qing, William Y., Taub, Jeffrey W., Ge, Yubin, Wang, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786928/
https://www.ncbi.nlm.nih.gov/pubmed/24098799
http://dx.doi.org/10.1371/journal.pone.0076662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786928/
https://www.ncbi.nlm.nih.gov/pubmed/24098799
http://dx.doi.org/10.1371/journal.pone.0076662

Ejemplares similares